This post was originally published on this site
German company CureVac
CVAC,
released the final results for its once-promising Covid-19 vaccine, finding it provided less protection than the vaccines already authorized for use in the U.S.
The company said Wednesday that its vaccine was 48% effective in providing protection against Covid-19 of any severity, regardless of age, in a large, pivotal study.
